APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Integrin Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Integrin Inhibitors Market Analysis and Forecast 2026-2032

Report ID 174003710229 December 2025217 pages

Choose your research edition.

Industry ResearchIntegrin Inhibitors Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Integrin Inhibitors Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Integrin Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Integrin Inhibitors Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Integrin Inhibitors Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Integrin Inhibitors market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Integrin Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Integrin Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Integrin Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Integrin Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Integrin Inhibitors include Grand Pharmaceutical, Yangtze River Pharmaceutical, Tianjin Chase Sun Pharma, SJZ No.4 Pharmaceutical, Lunan Pharma, Kelun Pharma, Huadong Medicin, Bio-Thera Solutions and Takeda, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Integrin Inhibitors, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Integrin Inhibitors, also provides the sales of main regions and countries. Of the upcoming market potential for Integrin Inhibitors, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Integrin Inhibitors sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Integrin Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Integrin Inhibitors sales, projected growth trends, production technology, application and end-user industry.

Integrin Inhibitors Segment by Company

Grand Pharmaceutical

Yangtze River Pharmaceutical

Tianjin Chase Sun Pharma

SJZ No.4 Pharmaceutical

Lunan Pharma

Kelun Pharma

Huadong Medicin

Bio-Thera Solutions

Takeda

Taj Pharmaceuticals

Sandoz

Polpharma Biologics

Novartis

Merck

Medicure

Johnson & Johnson

GlaxoSmithKline

Gland Pharma

Eli Lilly

Correvio

Biogen

Alvotech

Integrin Inhibitors Segment by Type

Antibodies

Small Molecules

Others

Integrin Inhibitors Segment by Application

Cardiovascular Disease

Tumor

Autoimmune Disease

Other

Integrin Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrin Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrin Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrin Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Integrin Inhibitors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Integrin Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Integrin Inhibitors sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Integrin Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Antibodies Major Manufacturers Table 3. Small Molecules Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Integrin Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cardiovascular Disease Major Manufacturers Table 7. Tumor Major Manufacturers Table 8. Autoimmune Disease Major Manufacturers Table 9. Other Major Manufacturers Table 10. Integrin Inhibitors Industry Trends Table 11. Integrin Inhibitors Industry Drivers Table 12. Integrin Inhibitors Industry Opportunities and Challenges Table 13. Integrin Inhibitors Industry Restraints Table 14. Global Integrin Inhibitors Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Integrin Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Integrin Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Integrin Inhibitors Revenue Market Share by Region (2021-2026) Table 18. Global Integrin Inhibitors Revenue Market Share by Region (2027-2032) Table 19. Global Integrin Inhibitors Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Integrin Inhibitors Sales by Region (2021-2026) & (K Units) Table 21. Global Integrin Inhibitors Sales by Region (2027-2032) & (K Units) Table 22. Global Integrin Inhibitors Sales Market Share by Region (2021-2026) Table 23. Global Integrin Inhibitors Sales Market Share by Region (2027-2032) Table 24. Global Integrin Inhibitors Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Integrin Inhibitors Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Integrin Inhibitors Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Integrin Inhibitors Sales Market Share by Manufacturers (2021-2026) Table 28. Global Integrin Inhibitors Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Integrin Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Integrin Inhibitors Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Integrin Inhibitors Manufacturers, Product Type & Application Table 32. Global Integrin Inhibitors Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Integrin Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Integrin Inhibitors Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Integrin Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Integrin Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Integrin Inhibitors Revenue Market Share by Type (2021-2026) Table 39. Global Integrin Inhibitors Revenue Market Share by Type (2027-2032) Table 40. Global Integrin Inhibitors Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Integrin Inhibitors Sales by Type (2021-2026) & (K Units) Table 42. Global Integrin Inhibitors Sales by Type (2027-2032) & (K Units) Table 43. Global Integrin Inhibitors Sales Market Share by Type (2021-2026) Table 44. Global Integrin Inhibitors Sales Market Share by Type (2027-2032) Table 45. Global Integrin Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 46. Global Integrin Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 47. Global Integrin Inhibitors Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Integrin Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Integrin Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Integrin Inhibitors Revenue Market Share by Application (2021-2026) Table 51. Global Integrin Inhibitors Revenue Market Share by Application (2027-2032) Table 52. Global Integrin Inhibitors Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Integrin Inhibitors Sales by Application (2021-2026) & (K Units) Table 54. Global Integrin Inhibitors Sales by Application (2027-2032) & (K Units) Table 55. Global Integrin Inhibitors Sales Market Share by Application (2021-2026) Table 56. Global Integrin Inhibitors Sales Market Share by Application (2027-2032) Table 57. Global Integrin Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 58. Global Integrin Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 59. Grand Pharmaceutical Company Information Table 60. Grand Pharmaceutical Business Overview Table 61. Grand Pharmaceutical Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Grand Pharmaceutical Integrin Inhibitors Product Portfolio Table 63. Grand Pharmaceutical Recent Development Table 64. Yangtze River Pharmaceutical Company Information Table 65. Yangtze River Pharmaceutical Business Overview Table 66. Yangtze River Pharmaceutical Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Yangtze River Pharmaceutical Integrin Inhibitors Product Portfolio Table 68. Yangtze River Pharmaceutical Recent Development Table 69. Tianjin Chase Sun Pharma Company Information Table 70. Tianjin Chase Sun Pharma Business Overview Table 71. Tianjin Chase Sun Pharma Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Tianjin Chase Sun Pharma Integrin Inhibitors Product Portfolio Table 73. Tianjin Chase Sun Pharma Recent Development Table 74. SJZ No.4 Pharmaceutical Company Information Table 75. SJZ No.4 Pharmaceutical Business Overview Table 76. SJZ No.4 Pharmaceutical Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. SJZ No.4 Pharmaceutical Integrin Inhibitors Product Portfolio Table 78. SJZ No.4 Pharmaceutical Recent Development Table 79. Lunan Pharma Company Information Table 80. Lunan Pharma Business Overview Table 81. Lunan Pharma Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Lunan Pharma Integrin Inhibitors Product Portfolio Table 83. Lunan Pharma Recent Development Table 84. Kelun Pharma Company Information Table 85. Kelun Pharma Business Overview Table 86. Kelun Pharma Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Kelun Pharma Integrin Inhibitors Product Portfolio Table 88. Kelun Pharma Recent Development Table 89. Huadong Medicin Company Information Table 90. Huadong Medicin Business Overview Table 91. Huadong Medicin Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Huadong Medicin Integrin Inhibitors Product Portfolio Table 93. Huadong Medicin Recent Development Table 94. Bio-Thera Solutions Company Information Table 95. Bio-Thera Solutions Business Overview Table 96. Bio-Thera Solutions Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Bio-Thera Solutions Integrin Inhibitors Product Portfolio Table 98. Bio-Thera Solutions Recent Development Table 99. Takeda Company Information Table 100. Takeda Business Overview Table 101. Takeda Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Takeda Integrin Inhibitors Product Portfolio Table 103. Takeda Recent Development Table 104. Taj Pharmaceuticals Company Information Table 105. Taj Pharmaceuticals Business Overview Table 106. Taj Pharmaceuticals Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Taj Pharmaceuticals Integrin Inhibitors Product Portfolio Table 108. Taj Pharmaceuticals Recent Development Table 109. Sandoz Company Information Table 110. Sandoz Business Overview Table 111. Sandoz Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Sandoz Integrin Inhibitors Product Portfolio Table 113. Sandoz Recent Development Table 114. Polpharma Biologics Company Information Table 115. Polpharma Biologics Business Overview Table 116. Polpharma Biologics Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Polpharma Biologics Integrin Inhibitors Product Portfolio Table 118. Polpharma Biologics Recent Development Table 119. Novartis Company Information Table 120. Novartis Business Overview Table 121. Novartis Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Novartis Integrin Inhibitors Product Portfolio Table 123. Novartis Recent Development Table 124. Merck Company Information Table 125. Merck Business Overview Table 126. Merck Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Merck Integrin Inhibitors Product Portfolio Table 128. Merck Recent Development Table 129. Medicure Company Information Table 130. Medicure Business Overview Table 131. Medicure Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Medicure Integrin Inhibitors Product Portfolio Table 133. Medicure Recent Development Table 134. Johnson & Johnson Company Information Table 135. Johnson & Johnson Business Overview Table 136. Johnson & Johnson Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Johnson & Johnson Integrin Inhibitors Product Portfolio Table 138. Johnson & Johnson Recent Development Table 139. GlaxoSmithKline Company Information Table 140. GlaxoSmithKline Business Overview Table 141. GlaxoSmithKline Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. GlaxoSmithKline Integrin Inhibitors Product Portfolio Table 143. GlaxoSmithKline Recent Development Table 144. Gland Pharma Company Information Table 145. Gland Pharma Business Overview Table 146. Gland Pharma Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Gland Pharma Integrin Inhibitors Product Portfolio Table 148. Gland Pharma Recent Development Table 149. Eli Lilly Company Information Table 150. Eli Lilly Business Overview Table 151. Eli Lilly Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Eli Lilly Integrin Inhibitors Product Portfolio Table 153. Eli Lilly Recent Development Table 154. Correvio Company Information Table 155. Correvio Business Overview Table 156. Correvio Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Correvio Integrin Inhibitors Product Portfolio Table 158. Correvio Recent Development Table 159. Biogen Company Information Table 160. Biogen Business Overview Table 161. Biogen Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Biogen Integrin Inhibitors Product Portfolio Table 163. Biogen Recent Development Table 164. Alvotech Company Information Table 165. Alvotech Business Overview Table 166. Alvotech Integrin Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Alvotech Integrin Inhibitors Product Portfolio Table 168. Alvotech Recent Development Table 169. North America Integrin Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 170. North America Integrin Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 171. North America Integrin Inhibitors Sales by Type (2021-2026) & (K Units) Table 172. North America Integrin Inhibitors Sales by Type (2027-2032) & (K Units) Table 173. North America Integrin Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 174. North America Integrin Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 175. North America Integrin Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 176. North America Integrin Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 177. North America Integrin Inhibitors Sales by Application (2021-2026) & (K Units) Table 178. North America Integrin Inhibitors Sales by Application (2027-2032) & (K Units) Table 179. North America Integrin Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 180. North America Integrin Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 181. North America Integrin Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. North America Integrin Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. North America Integrin Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. North America Integrin Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 185. North America Integrin Inhibitors Sales by Country (2021-2026) & (K Units) Table 186. North America Integrin Inhibitors Sales by Country (2027-2032) & (K Units) Table 187. North America Integrin Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 188. North America Integrin Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 189. United States Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 190. Canada Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 191. Mexico Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 192. Europe Integrin Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 193. Europe Integrin Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 194. Europe Integrin Inhibitors Sales by Type (2021-2026) & (K Units) Table 195. Europe Integrin Inhibitors Sales by Type (2027-2032) & (K Units) Table 196. Europe Integrin Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 197. Europe Integrin Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 198. Europe Integrin Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 199. Europe Integrin Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 200. Europe Integrin Inhibitors Sales by Application (2021-2026) & (K Units) Table 201. Europe Integrin Inhibitors Sales by Application (2027-2032) & (K Units) Table 202. Europe Integrin Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 203. Europe Integrin Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 204. Europe Integrin Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. Europe Integrin Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. Europe Integrin Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. Europe Integrin Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 208. Europe Integrin Inhibitors Sales by Country (2021-2026) & (K Units) Table 209. Europe Integrin Inhibitors Sales by Country (2027-2032) & (K Units) Table 210. Europe Integrin Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 211. Europe Integrin Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 212. Germany Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 213. France Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 214. U.K. Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 215. Italy Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 216. Russia Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 217. Spain Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 218. Netherlands Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 219. Switzerland Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 220. Sweden Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 221. Poland Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 222. China Integrin Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 223. China Integrin Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 224. China Integrin Inhibitors Sales by Type (2021-2026) & (K Units) Table 225. China Integrin Inhibitors Sales by Type (2027-2032) & (K Units) Table 226. China Integrin Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 227. China Integrin Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 228. China Integrin Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 229. China Integrin Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 230. China Integrin Inhibitors Sales by Application (2021-2026) & (K Units) Table 231. China Integrin Inhibitors Sales by Application (2027-2032) & (K Units) Table 232. China Integrin Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 233. China Integrin Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 234. Asia Integrin Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 235. Asia Integrin Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 236. Asia Integrin Inhibitors Sales by Type (2021-2026) & (K Units) Table 237. Asia Integrin Inhibitors Sales by Type (2027-2032) & (K Units) Table 238. Asia Integrin Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 239. Asia Integrin Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 240. Asia Integrin Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 241. Asia Integrin Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 242. Asia Integrin Inhibitors Sales by Application (2021-2026) & (K Units) Table 243. Asia Integrin Inhibitors Sales by Application (2027-2032) & (K Units) Table 244. Asia Integrin Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 245. Asia Integrin Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 246. Asia Integrin Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 247. Asia Integrin Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 248. Asia Integrin Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 249. Asia Integrin Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 250. Asia Integrin Inhibitors Sales by Country (2021-2026) & (K Units) Table 251. Asia Integrin Inhibitors Sales by Country (2027-2032) & (K Units) Table 252. Asia Integrin Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 253. Asia Integrin Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 254. Japan Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 255. South Korea Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 256. India Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 257. Australia Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 258. Taiwan Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 259. Southeast Asia Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 260. SAMEA Integrin Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 261. SAMEA Integrin Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 262. SAMEA Integrin Inhibitors Sales by Type (2021-2026) & (K Units) Table 263. SAMEA Integrin Inhibitors Sales by Type (2027-2032) & (K Units) Table 264. SAMEA Integrin Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 265. SAMEA Integrin Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 266. SAMEA Integrin Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 267. SAMEA Integrin Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 268. SAMEA Integrin Inhibitors Sales by Application (2021-2026) & (K Units) Table 269. SAMEA Integrin Inhibitors Sales by Application (2027-2032) & (K Units) Table 270. SAMEA Integrin Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 271. SAMEA Integrin Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 272. SAMEA Integrin Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 273. SAMEA Integrin Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 274. SAMEA Integrin Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 275. SAMEA Integrin Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 276. SAMEA Integrin Inhibitors Sales by Country (2021-2026) & (K Units) Table 277. SAMEA Integrin Inhibitors Sales by Country (2027-2032) & (K Units) Table 278. SAMEA Integrin Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 279. SAMEA Integrin Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 280. Brazil Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 281. Argentina Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 282. Chile Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 283. Colombia Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 284. Peru Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 285. Saudi Arabia Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 286. Israel Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 287. UAE Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 288. Turkey Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 289. Iran Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 290. Egypt Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Table 291. Key Raw Materials Table 292. Raw Materials Key Suppliers Table 293. Integrin Inhibitors Distributors List Table 294. Integrin Inhibitors Customers List Table 295. Research Programs/Design for This Report Table 296. Authors List of This Report Table 297. Secondary Sources Table 298. Primary Sources List of Figures Figure 1. Integrin Inhibitors Image Figure 2. Global Integrin Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Integrin Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 4. Antibodies Image Figure 5. Small Molecules Image Figure 6. Others Image Figure 7. Global Integrin Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Integrin Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cardiovascular Disease Image Figure 10. Tumor Image Figure 11. Autoimmune Disease Image Figure 12. Other Image Figure 13. Global Integrin Inhibitors Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Integrin Inhibitors Revenue (2021-2032) & (US$ Million) Figure 15. Global Integrin Inhibitors Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Integrin Inhibitors Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Integrin Inhibitors Revenue Market Share by Region (2021-2032) Figure 18. Global Integrin Inhibitors Sales (2021-2032) & (K Units) Figure 19. Global Integrin Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Integrin Inhibitors Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Integrin Inhibitors Sales YoY (2021-2032) & (K Units) Figure 22. Europe Integrin Inhibitors Sales YoY (2021-2032) & (K Units) Figure 23. China Integrin Inhibitors Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Integrin Inhibitors Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Integrin Inhibitors Sales YoY (2021-2032) & (K Units) Figure 26. Global Integrin Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Integrin Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Integrin Inhibitors Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Integrin Inhibitors Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Integrin Inhibitors Revenue Market Share by Type (2021-2032) Figure 32. Global Integrin Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Integrin Inhibitors Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Integrin Inhibitors Sales Market Share by Type (2021-2032) Figure 35. Global Integrin Inhibitors Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Integrin Inhibitors Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Integrin Inhibitors Revenue Market Share by Application (2021-2032) Figure 38. Global Integrin Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Integrin Inhibitors Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Integrin Inhibitors Sales Market Share by Application (2021-2032) Figure 41. North America Integrin Inhibitors Revenue Share by Type (2021-2032) Figure 42. North America Integrin Inhibitors Sales Share by Type (2021-2032) Figure 43. North America Integrin Inhibitors Revenue Share by Application (2021-2032) Figure 44. North America Integrin Inhibitors Sales Share by Application (2021-2032) Figure 45. North America Integrin Inhibitors Revenue Share by Country (2021-2032) Figure 46. North America Integrin Inhibitors Sales Share by Country (2021-2032) Figure 47. Europe Integrin Inhibitors Revenue Share by Type (2021-2032) Figure 48. Europe Integrin Inhibitors Sales Share by Type (2021-2032) Figure 49. Europe Integrin Inhibitors Revenue Share by Application (2021-2032) Figure 50. Europe Integrin Inhibitors Sales Share by Application (2021-2032) Figure 51. Europe Integrin Inhibitors Revenue Share by Country (2021-2032) Figure 52. Europe Integrin Inhibitors Sales Share by Country (2021-2032) Figure 53. China Integrin Inhibitors Revenue Share by Type (2021-2032) Figure 54. China Integrin Inhibitors Sales Share by Type (2021-2032) Figure 55. China Integrin Inhibitors Revenue Share by Application (2021-2032) Figure 56. China Integrin Inhibitors Sales Share by Application (2021-2032) Figure 57. Asia Integrin Inhibitors Revenue Share by Type (2021-2032) Figure 58. Asia Integrin Inhibitors Sales Share by Type (2021-2032) Figure 59. Asia Integrin Inhibitors Revenue Share by Application (2021-2032) Figure 60. Asia Integrin Inhibitors Sales Share by Application (2021-2032) Figure 61. Asia Integrin Inhibitors Revenue Share by Country (2021-2032) Figure 62. Asia Integrin Inhibitors Sales Share by Country (2021-2032) Figure 63. SAMEA Integrin Inhibitors Revenue Share by Type (2021-2032) Figure 64. SAMEA Integrin Inhibitors Sales Share by Type (2021-2032) Figure 65. SAMEA Integrin Inhibitors Revenue Share by Application (2021-2032) Figure 66. SAMEA Integrin Inhibitors Sales Share by Application (2021-2032) Figure 67. SAMEA Integrin Inhibitors Revenue Share by Country (2021-2032) Figure 68. SAMEA Integrin Inhibitors Sales Share by Country (2021-2032) Figure 69. Integrin Inhibitors Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Integrin Inhibitors Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Antibodies
  • Small Molecules
  • Others
Applications
  • Cardiovascular Disease
  • Tumor
  • Autoimmune Disease
  • Other
Companies covered
  • Grand Pharmaceutical
  • Yangtze River Pharmaceutical
  • Tianjin Chase Sun Pharma
  • SJZ No.4 Pharmaceutical
  • Lunan Pharma
  • Kelun Pharma
  • Huadong Medicin
  • Bio-Thera Solutions
  • Takeda
  • Taj Pharmaceuticals
  • Sandoz
  • Polpharma Biologics
  • Novartis
  • Merck
  • Medicure
  • Johnson & Johnson
  • GlaxoSmithKline
  • Gland Pharma
  • Eli Lilly
  • Correvio
  • Biogen
  • Alvotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Integrin Inhibitors Market by Type
  3. 1.2.1 Global Integrin Inhibitors Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Antibodies
  5. 1.2.3 Small Molecules
  6. 1.2.4 Others
  7. 1.3 Integrin Inhibitors Market by Application
  8. 1.3.1 Global Integrin Inhibitors Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cardiovascular Disease
  10. 1.3.3 Tumor
  11. 1.3.4 Autoimmune Disease
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Integrin Inhibitors Market Dynamics
  1. 2.1 Integrin Inhibitors Industry Trends
  2. 2.2 Integrin Inhibitors Industry Drivers
  3. 2.3 Integrin Inhibitors Industry Opportunities and Challenges
  4. 2.4 Integrin Inhibitors Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Integrin Inhibitors Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Integrin Inhibitors Revenue by Region
  3. 3.2.1 Global Integrin Inhibitors Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Integrin Inhibitors Revenue by Region (2021-2026)
  5. 3.2.3 Global Integrin Inhibitors Revenue by Region (2027-2032)
  6. 3.2.4 Global Integrin Inhibitors Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Integrin Inhibitors Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Integrin Inhibitors Sales by Region
  9. 3.4.1 Global Integrin Inhibitors Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Integrin Inhibitors Sales by Region (2021-2026)
  11. 3.4.3 Global Integrin Inhibitors Sales by Region (2027-2032)
  12. 3.4.4 Global Integrin Inhibitors Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Integrin Inhibitors Revenue by Manufacturers
  2. 4.1.1 Global Integrin Inhibitors Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Integrin Inhibitors Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Integrin Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Integrin Inhibitors Sales by Manufacturers
  6. 4.2.1 Global Integrin Inhibitors Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Integrin Inhibitors Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Integrin Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Integrin Inhibitors Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Integrin Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Integrin Inhibitors Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Integrin Inhibitors Manufacturers, Product Type & Application
  13. 4.7 Global Integrin Inhibitors Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Integrin Inhibitors Market CR5 and HHI
  16. 4.8.2 2025 Integrin Inhibitors Tier 1, Tier 2, and Tier 3
5 Integrin Inhibitors Market by Type
  1. 5.1 Global Integrin Inhibitors Revenue by Type
  2. 5.1.1 Global Integrin Inhibitors Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Integrin Inhibitors Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Integrin Inhibitors Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Integrin Inhibitors Sales by Type
  6. 5.2.1 Global Integrin Inhibitors Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Integrin Inhibitors Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Integrin Inhibitors Sales Market Share by Type (2021-2032)
  9. 5.3 Global Integrin Inhibitors Price by Type
6 Integrin Inhibitors Market by Application
  1. 6.1 Global Integrin Inhibitors Revenue by Application
  2. 6.1.1 Global Integrin Inhibitors Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Integrin Inhibitors Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Integrin Inhibitors Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Integrin Inhibitors Sales by Application
  6. 6.2.1 Global Integrin Inhibitors Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Integrin Inhibitors Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Integrin Inhibitors Sales Market Share by Application (2021-2032)
  9. 6.3 Global Integrin Inhibitors Price by Application
7 Company Profiles
  1. 7.1 Grand Pharmaceutical
  2. 7.1.1 Grand Pharmaceutical Company Information
  3. 7.1.2 Grand Pharmaceutical Business Overview
  4. 7.1.3 Grand Pharmaceutical Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Grand Pharmaceutical Integrin Inhibitors Product Portfolio
  6. 7.1.5 Grand Pharmaceutical Recent Developments
  7. 7.2 Yangtze River Pharmaceutical
  8. 7.2.1 Yangtze River Pharmaceutical Company Information
  9. 7.2.2 Yangtze River Pharmaceutical Business Overview
  10. 7.2.3 Yangtze River Pharmaceutical Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Yangtze River Pharmaceutical Integrin Inhibitors Product Portfolio
  12. 7.2.5 Yangtze River Pharmaceutical Recent Developments
  13. 7.3 Tianjin Chase Sun Pharma
  14. 7.3.1 Tianjin Chase Sun Pharma Company Information
  15. 7.3.2 Tianjin Chase Sun Pharma Business Overview
  16. 7.3.3 Tianjin Chase Sun Pharma Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Tianjin Chase Sun Pharma Integrin Inhibitors Product Portfolio
  18. 7.3.5 Tianjin Chase Sun Pharma Recent Developments
  19. 7.4 SJZ No.4 Pharmaceutical
  20. 7.4.1 SJZ No.4 Pharmaceutical Company Information
  21. 7.4.2 SJZ No.4 Pharmaceutical Business Overview
  22. 7.4.3 SJZ No.4 Pharmaceutical Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 SJZ No.4 Pharmaceutical Integrin Inhibitors Product Portfolio
  24. 7.4.5 SJZ No.4 Pharmaceutical Recent Developments
  25. 7.5 Lunan Pharma
  26. 7.5.1 Lunan Pharma Company Information
  27. 7.5.2 Lunan Pharma Business Overview
  28. 7.5.3 Lunan Pharma Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Lunan Pharma Integrin Inhibitors Product Portfolio
  30. 7.5.5 Lunan Pharma Recent Developments
  31. 7.6 Kelun Pharma
  32. 7.6.1 Kelun Pharma Company Information
  33. 7.6.2 Kelun Pharma Business Overview
  34. 7.6.3 Kelun Pharma Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Kelun Pharma Integrin Inhibitors Product Portfolio
  36. 7.6.5 Kelun Pharma Recent Developments
  37. 7.7 Huadong Medicin
  38. 7.7.1 Huadong Medicin Company Information
  39. 7.7.2 Huadong Medicin Business Overview
  40. 7.7.3 Huadong Medicin Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Huadong Medicin Integrin Inhibitors Product Portfolio
  42. 7.7.5 Huadong Medicin Recent Developments
  43. 7.8 Bio-Thera Solutions
  44. 7.8.1 Bio-Thera Solutions Company Information
  45. 7.8.2 Bio-Thera Solutions Business Overview
  46. 7.8.3 Bio-Thera Solutions Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bio-Thera Solutions Integrin Inhibitors Product Portfolio
  48. 7.8.5 Bio-Thera Solutions Recent Developments
  49. 7.9 Takeda
  50. 7.9.1 Takeda Company Information
  51. 7.9.2 Takeda Business Overview
  52. 7.9.3 Takeda Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Takeda Integrin Inhibitors Product Portfolio
  54. 7.9.5 Takeda Recent Developments
  55. 7.10 Taj Pharmaceuticals
  56. 7.10.1 Taj Pharmaceuticals Company Information
  57. 7.10.2 Taj Pharmaceuticals Business Overview
  58. 7.10.3 Taj Pharmaceuticals Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Taj Pharmaceuticals Integrin Inhibitors Product Portfolio
  60. 7.10.5 Taj Pharmaceuticals Recent Developments
  61. 7.11 Sandoz
  62. 7.11.1 Sandoz Company Information
  63. 7.11.2 Sandoz Business Overview
  64. 7.11.3 Sandoz Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sandoz Integrin Inhibitors Product Portfolio
  66. 7.11.5 Sandoz Recent Developments
  67. 7.12 Polpharma Biologics
  68. 7.12.1 Polpharma Biologics Company Information
  69. 7.12.2 Polpharma Biologics Business Overview
  70. 7.12.3 Polpharma Biologics Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Polpharma Biologics Integrin Inhibitors Product Portfolio
  72. 7.12.5 Polpharma Biologics Recent Developments
  73. 7.13 Novartis
  74. 7.13.1 Novartis Company Information
  75. 7.13.2 Novartis Business Overview
  76. 7.13.3 Novartis Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Novartis Integrin Inhibitors Product Portfolio
  78. 7.13.5 Novartis Recent Developments
  79. 7.14 Merck
  80. 7.14.1 Merck Company Information
  81. 7.14.2 Merck Business Overview
  82. 7.14.3 Merck Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Merck Integrin Inhibitors Product Portfolio
  84. 7.14.5 Merck Recent Developments
  85. 7.15 Medicure
  86. 7.15.1 Medicure Company Information
  87. 7.15.2 Medicure Business Overview
  88. 7.15.3 Medicure Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Medicure Integrin Inhibitors Product Portfolio
  90. 7.15.5 Medicure Recent Developments
  91. 7.16 Johnson & Johnson
  92. 7.16.1 Johnson & Johnson Company Information
  93. 7.16.2 Johnson & Johnson Business Overview
  94. 7.16.3 Johnson & Johnson Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Johnson & Johnson Integrin Inhibitors Product Portfolio
  96. 7.16.5 Johnson & Johnson Recent Developments
  97. 7.17 GlaxoSmithKline
  98. 7.17.1 GlaxoSmithKline Company Information
  99. 7.17.2 GlaxoSmithKline Business Overview
  100. 7.17.3 GlaxoSmithKline Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 GlaxoSmithKline Integrin Inhibitors Product Portfolio
  102. 7.17.5 GlaxoSmithKline Recent Developments
  103. 7.18 Gland Pharma
  104. 7.18.1 Gland Pharma Company Information
  105. 7.18.2 Gland Pharma Business Overview
  106. 7.18.3 Gland Pharma Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Gland Pharma Integrin Inhibitors Product Portfolio
  108. 7.18.5 Gland Pharma Recent Developments
  109. 7.19 Eli Lilly
  110. 7.19.1 Eli Lilly Company Information
  111. 7.19.2 Eli Lilly Business Overview
  112. 7.19.3 Eli Lilly Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Eli Lilly Integrin Inhibitors Product Portfolio
  114. 7.19.5 Eli Lilly Recent Developments
  115. 7.20 Correvio
  116. 7.20.1 Correvio Company Information
  117. 7.20.2 Correvio Business Overview
  118. 7.20.3 Correvio Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Correvio Integrin Inhibitors Product Portfolio
  120. 7.20.5 Correvio Recent Developments
  121. 7.21 Biogen
  122. 7.21.1 Biogen Company Information
  123. 7.21.2 Biogen Business Overview
  124. 7.21.3 Biogen Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Biogen Integrin Inhibitors Product Portfolio
  126. 7.21.5 Biogen Recent Developments
  127. 7.22 Alvotech
  128. 7.22.1 Alvotech Company Information
  129. 7.22.2 Alvotech Business Overview
  130. 7.22.3 Alvotech Integrin Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Alvotech Integrin Inhibitors Product Portfolio
  132. 7.22.5 Alvotech Recent Developments
8 North America
  1. 8.1 North America Integrin Inhibitors Market Size by Type
  2. 8.1.1 North America Integrin Inhibitors Revenue by Type (2021-2032)
  3. 8.1.2 North America Integrin Inhibitors Sales by Type (2021-2032)
  4. 8.1.3 North America Integrin Inhibitors Price by Type (2021-2032)
  5. 8.2 North America Integrin Inhibitors Market Size by Application
  6. 8.2.1 North America Integrin Inhibitors Revenue by Application (2021-2032)
  7. 8.2.2 North America Integrin Inhibitors Sales by Application (2021-2032)
  8. 8.2.3 North America Integrin Inhibitors Price by Application (2021-2032)
  9. 8.3 North America Integrin Inhibitors Market Size by Country
  10. 8.3.1 North America Integrin Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Integrin Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Integrin Inhibitors Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Integrin Inhibitors Market Size by Type
  2. 9.1.1 Europe Integrin Inhibitors Revenue by Type (2021-2032)
  3. 9.1.2 Europe Integrin Inhibitors Sales by Type (2021-2032)
  4. 9.1.3 Europe Integrin Inhibitors Price by Type (2021-2032)
  5. 9.2 Europe Integrin Inhibitors Market Size by Application
  6. 9.2.1 Europe Integrin Inhibitors Revenue by Application (2021-2032)
  7. 9.2.2 Europe Integrin Inhibitors Sales by Application (2021-2032)
  8. 9.2.3 Europe Integrin Inhibitors Price by Application (2021-2032)
  9. 9.3 Europe Integrin Inhibitors Market Size by Country
  10. 9.3.1 Europe Integrin Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Integrin Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Integrin Inhibitors Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Integrin Inhibitors Market Size by Type
  2. 10.1.1 China Integrin Inhibitors Revenue by Type (2021-2032)
  3. 10.1.2 China Integrin Inhibitors Sales by Type (2021-2032)
  4. 10.1.3 China Integrin Inhibitors Price by Type (2021-2032)
  5. 10.2 China Integrin Inhibitors Market Size by Application
  6. 10.2.1 China Integrin Inhibitors Revenue by Application (2021-2032)
  7. 10.2.2 China Integrin Inhibitors Sales by Application (2021-2032)
  8. 10.2.3 China Integrin Inhibitors Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Integrin Inhibitors Market Size by Type
  2. 11.1.1 Asia Integrin Inhibitors Revenue by Type (2021-2032)
  3. 11.1.2 Asia Integrin Inhibitors Sales by Type (2021-2032)
  4. 11.1.3 Asia Integrin Inhibitors Price by Type (2021-2032)
  5. 11.2 Asia Integrin Inhibitors Market Size by Application
  6. 11.2.1 Asia Integrin Inhibitors Revenue by Application (2021-2032)
  7. 11.2.2 Asia Integrin Inhibitors Sales by Application (2021-2032)
  8. 11.2.3 Asia Integrin Inhibitors Price by Application (2021-2032)
  9. 11.3 Asia Integrin Inhibitors Market Size by Country
  10. 11.3.1 Asia Integrin Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Integrin Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Integrin Inhibitors Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Integrin Inhibitors Market Size by Type
  2. 12.1.1 SAMEA Integrin Inhibitors Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Integrin Inhibitors Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Integrin Inhibitors Price by Type (2021-2032)
  5. 12.2 SAMEA Integrin Inhibitors Market Size by Application
  6. 12.2.1 SAMEA Integrin Inhibitors Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Integrin Inhibitors Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Integrin Inhibitors Price by Application (2021-2032)
  9. 12.3 SAMEA Integrin Inhibitors Market Size by Country
  10. 12.3.1 SAMEA Integrin Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Integrin Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Integrin Inhibitors Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Integrin Inhibitors Value Chain Analysis
  2. 13.1.1 Integrin Inhibitors Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Integrin Inhibitors Production Mode & Process
  6. 13.2 Integrin Inhibitors Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Integrin Inhibitors Distributors
  9. 13.2.3 Integrin Inhibitors Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst